drugset / Trial / NCT03082573

Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel

NCT03082573

RandomizedCrossoverOpen-labelTreatment

Summary

This study will examine the clinical response, cytokine expression and joint imaging after addition of Acthar Gel. The hypothesis is that H.P. Acthar Gel is both safe and effective for treatment of patients with refractory rheumatoid arthritis (RA) and has different mechanism of action than steroids and other DMARDs.

Timeline

Start
2017-03-03
Primary completion
2018-02
Completion
2019-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acthar Peptide 40 iu
Comparator Acthar Peptide 80 iu

Indications